Skip to main content
Erschienen in: Netherlands Heart Journal 7-8/2011

01.08.2011 | Original Article

Failure of epicardial pacing leads in congenital heart disease: not uncommon and difficult to predict

verfasst von: M. C. Post, W. Budts, A. Van de Bruaene, R. Willems, B. Meyns, F. Rega, M. Gewillig

Erschienen in: Netherlands Heart Journal | Ausgabe 7-8/2011

Einloggen, um Zugang zu erhalten

Abstract

Aims

We evaluate the incidence of epicardial lead failure and try to identify risk factors in patients with congenital heart disease.

Methods

All patients with a congenital heart defect and an epicardial pacing system, implanted within a timeframe of 25 years, were included in this study. Patients’ medical records and lead data were reviewed. Lead failure was defined as the primary endpoint.

Results

In total 198 active epicardial leads (atrial 40, ventricular 158) were implanted in 93 patients (median age at implantation 4.4 years (range 0–58.6)). During a total follow-up of 1235 lead-years, 29 lead failures (14.6%, 4 atrial, 25 ventricular) were documented in 22 patients (23.7%). Lead failure occurred at a median time period of 4.8 years (range 1.2–24.1) after implantation. Five-year freedom of lead failure was 88%. The only independent predictor for lead failure was the age at implantation (HR 0.44; 95%CI 0.20–0.97, p = 0.04), other characteristics failed to predict lead failure. Sudden cardiac death occurred in four patients (4.3%), in one a lead failure was documented.

Conclusion

A high incidence of epicardial lead failures is found in patients with congenital heart disease. Unfortunately, it is difficult to predict this potentially life-threatening complication.
Literatur
1.
Zurück zum Zitat Fortescue EB, Berul CI, Cecchin F, et al. Comparison of modern steroid-eluting epicardial and thin transvenous pacemaker leads in pediatric and congenital heart disease patients. J Interv Card Electrophysiol. 2005;14:27–36.PubMedCrossRef Fortescue EB, Berul CI, Cecchin F, et al. Comparison of modern steroid-eluting epicardial and thin transvenous pacemaker leads in pediatric and congenital heart disease patients. J Interv Card Electrophysiol. 2005;14:27–36.PubMedCrossRef
2.
Zurück zum Zitat Beaufort-Krol GC, Mulder H, Nagelkerke D, et al. Comparison of longevity, pacing, and sensing characteristics of steroid-eluting epicardial versus conventional endocardial pacing leads in children. J Thorac Cardiovasc Surg. 1999;117:523–8.PubMedCrossRef Beaufort-Krol GC, Mulder H, Nagelkerke D, et al. Comparison of longevity, pacing, and sensing characteristics of steroid-eluting epicardial versus conventional endocardial pacing leads in children. J Thorac Cardiovasc Surg. 1999;117:523–8.PubMedCrossRef
3.
Zurück zum Zitat Ector B, Willems R, Heidbuchel H, et al. Epicardial pacing: a single-centre study on 321 leads in 138 patients. Acta Cardiol. 2006;61:343–51.PubMedCrossRef Ector B, Willems R, Heidbuchel H, et al. Epicardial pacing: a single-centre study on 321 leads in 138 patients. Acta Cardiol. 2006;61:343–51.PubMedCrossRef
4.
Zurück zum Zitat Cohen MI, Bush DM, Vetter VL, et al. Permanent epicardial pacing in pediatric patients: seventeen years of experience and 1200 outpatient visits. Circulation. 2001;103:2585–90.PubMed Cohen MI, Bush DM, Vetter VL, et al. Permanent epicardial pacing in pediatric patients: seventeen years of experience and 1200 outpatient visits. Circulation. 2001;103:2585–90.PubMed
5.
Zurück zum Zitat Silvetti MS, Drago F, Grutter G, et al. Twenty years of paediatric cardiac pacing: 515 pacemakers and 480 leads implanted in 292 patients. Europace. 2006;8:530–6.PubMedCrossRef Silvetti MS, Drago F, Grutter G, et al. Twenty years of paediatric cardiac pacing: 515 pacemakers and 480 leads implanted in 292 patients. Europace. 2006;8:530–6.PubMedCrossRef
6.
Zurück zum Zitat Murayama H, Maeda M, Sakurai H, et al. Predictors affecting durability of epicardial pacemaker leads in pediatric patients. J Thorac Cardiovasc Surg. 2008;135:361–6.PubMedCrossRef Murayama H, Maeda M, Sakurai H, et al. Predictors affecting durability of epicardial pacemaker leads in pediatric patients. J Thorac Cardiovasc Surg. 2008;135:361–6.PubMedCrossRef
7.
Zurück zum Zitat ten Udink CF, Breur J, Boramanand N, et al. Endocardial and epicardial steroid lead pacing in the neonatal and paediatric age group. Heart. 2002;88:392–6.CrossRef ten Udink CF, Breur J, Boramanand N, et al. Endocardial and epicardial steroid lead pacing in the neonatal and paediatric age group. Heart. 2002;88:392–6.CrossRef
8.
Zurück zum Zitat Tomaske M, Gerritse B, Kretzers L, et al. A 12-year experience of bipolar steroid-eluting epicardial pacing leads in children. Ann Thorac Surg. 2008;85:1704–11.PubMedCrossRef Tomaske M, Gerritse B, Kretzers L, et al. A 12-year experience of bipolar steroid-eluting epicardial pacing leads in children. Ann Thorac Surg. 2008;85:1704–11.PubMedCrossRef
9.
Zurück zum Zitat Sachweh JS, Vazquez-Jimenez JF, Schondube FA, et al. Twenty years experience with pediatric pacing: epicardial and transvenous stimulation. Eur J Cardiothorac Surg. 2000;17:455–61.PubMedCrossRef Sachweh JS, Vazquez-Jimenez JF, Schondube FA, et al. Twenty years experience with pediatric pacing: epicardial and transvenous stimulation. Eur J Cardiothorac Surg. 2000;17:455–61.PubMedCrossRef
10.
Zurück zum Zitat Horenstein MS, Hakimi M, Walters III H, et al. Chronic performance of steroid-eluting epicardial leads in a growing pediatric population: a 10-year comparison. Pacing Clin Electrophysiol. 2003;26:1467–71.PubMedCrossRef Horenstein MS, Hakimi M, Walters III H, et al. Chronic performance of steroid-eluting epicardial leads in a growing pediatric population: a 10-year comparison. Pacing Clin Electrophysiol. 2003;26:1467–71.PubMedCrossRef
11.
Zurück zum Zitat Fortescue EB, Berul CI, Cecchin F, et al. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm. 2004;1:150–9.PubMedCrossRef Fortescue EB, Berul CI, Cecchin F, et al. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm. 2004;1:150–9.PubMedCrossRef
12.
Zurück zum Zitat Cutler NG, Karpawich PP, Cavitt D, et al. Steroid-eluting epicardial pacing electrodes: six year experience of pacing thresholds in a growing pediatric population. Pacing Clin Electrophysiol. 1997;20:2943–8.PubMedCrossRef Cutler NG, Karpawich PP, Cavitt D, et al. Steroid-eluting epicardial pacing electrodes: six year experience of pacing thresholds in a growing pediatric population. Pacing Clin Electrophysiol. 1997;20:2943–8.PubMedCrossRef
13.
Zurück zum Zitat Crossley GH, Brinker JA, Reynolds D, et al. Steroid elution improves the stimulation threshold in an active-fixation atrial permanent pacing lead. A randomized, controlled study. Model 4068 Investigators. Circulation. 1995;92:2935–9.PubMed Crossley GH, Brinker JA, Reynolds D, et al. Steroid elution improves the stimulation threshold in an active-fixation atrial permanent pacing lead. A randomized, controlled study. Model 4068 Investigators. Circulation. 1995;92:2935–9.PubMed
14.
Zurück zum Zitat Johns JA, Fish FA, Burger JD, et al. Steroid-eluting epicardial pacing leads in pediatric patients: encouraging early results. J Am Coll Cardiol. 1992;20:395–401.PubMedCrossRef Johns JA, Fish FA, Burger JD, et al. Steroid-eluting epicardial pacing leads in pediatric patients: encouraging early results. J Am Coll Cardiol. 1992;20:395–401.PubMedCrossRef
Metadaten
Titel
Failure of epicardial pacing leads in congenital heart disease: not uncommon and difficult to predict
verfasst von
M. C. Post
W. Budts
A. Van de Bruaene
R. Willems
B. Meyns
F. Rega
M. Gewillig
Publikationsdatum
01.08.2011
Verlag
Bohn Stafleu van Loghum
Erschienen in
Netherlands Heart Journal / Ausgabe 7-8/2011
Print ISSN: 1568-5888
Elektronische ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-011-0158-5

Weitere Artikel der Ausgabe 7-8/2011

Netherlands Heart Journal 7-8/2011 Zur Ausgabe

Rhythm Puzzle - Question

A young man with near-syncope

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Weniger Extremitätenischämien mit dualer Plättchenhemmung

02.05.2024 Thrombozytenaggregationshemmer Nachrichten

Eine Behandlung mit Ticagrelor zusätzlich zu ASS kann das Risiko für Revaskularisierungen und Amputationen von Extremitäten bei Diabetikern mit stabiler KHK deutlich reduzieren, vor allem für solche mit PAVK. Dafür spricht eine Auswertung der Interventionsstudie THEMIS.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.